Choosing Between Continuing Vitamin K Antagonists (VKA) or Switching to a Direct Oral Anticoagulant in Currently Well-Controlled Patients on VKA for Atrial Fibrillation: A Randomised Controlled Trial (GAInN)
British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15856
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 6, 2019
Authors
Publisher
Wiley